Suki, a ‘Siri’ for Doctors, Just Raised $90 Million

Suki previously raised a $70 million Series D round in October 2024. A source familiar with the deal told Reuters at the time that the post-money valuation following the Series D was close to $500 million.

Punit Soni, founder and CEO of Suki, says he hopes his platform will allow physicians to be more present when interacting with patients. “A clinician would be able to focus on you a lot more,” says Soni, outlining a world in which his tech has been implemented widely across the healthcare ecosystem. “A clinician might be able to see a lot more patients. Not only that, there might be situations in the future where the patient can have a lot of the stuff that they have to do automatically done for them.”

In that world, he adds, “human interaction is all that matters; technology fades back into the background.”

It’s a far-reaching vision for Suki, which currently automates aspects of clinical note-taking as well as revenue cycle management, operational workflows and—following the recent launch of an AI tool called Suki Ask—best-practice medical guidance.

“Think of it like a Siri, but for healthcare,” Soni says of the platform, which is now used by over 450 healthcare organizations, according to the company. In addition to the main Suki app, Soni says the company has a second line of business in licensing Suki to other health-tech companies who then build their own tools on top of the underlying AI tech; those partners number over 30.

Soni, who founded Suki in 2017 after stints at Google and the Indian e-commerce company Flipkart, says this is his first real foray into the healthcare industry. His early observations of the space showed that there was much room for improvement.

“When I started looking at it as an outsider, what I noticed is 88 percent of all doctors did not want to recommend this profession to their kids,” he says. “They were burning out, retiring early, leaving practice, cutting down on patients because the amount of administrative work and documentation work they had to do was multiple hours every single day.”

The new capital, he adds, will go toward using agentic AI to automate some of the tasks that might emerge from a patient encounter, such as setting up referrals or facilitating scheduling.

“We are going to be using the money to be able to scale our ambient clinical intelligence capabilities and add agentic capabilities on top of it,” says Soni, so that customers and partners are able to not only use Suki to “document, get financial information [and] reason, but are also able to use it to do the tasks that are emanating out of that encounter.”

Other participants in the funding round included new backer Crosslink Capital as well as returning investors Venrock, Flare Capital Partners and Hedosophia. Suki is not sharing an updated post-money valuation following its $90 million raise, but notes that revenue doubled across 2025 and is on track to perform similarly this year.